SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 13D

 

Under the Securities Exchange Act of 1934

 

Alon USA Energy, Inc.

 

(Name of Issuer)

 

Common Stock, par value $0.01 per share

 

(Title of Class of Securities)

 

020520102

 

(CUSIP Number)

 

D. E. Shaw & Co., L.P.

Attn: Compliance Department

1166 Avenue of the Americas, 9th Floor

New York, NY 10036

212-478-0000

 

(Name, Address and Telephone Number of Person

Authorized to Receive Notices and Communications)

 

July 17, 2015

 

(Date of Event which Requires Filing of this Statement)

 

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box: x

 

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 240.13d-7 for other parties to whom copies are to be sent.

 

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

 

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 
 

 

SCHEDULE 13D

 

CUSIP No. 020520102    

1

NAME OF REPORTING PERSON

I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

D. E. Shaw Kalon Portfolios, L.L.C.

FEIN 27-1490745

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

 

(a) ¨

(b) ¨

3 SEC USE ONLY
4

SOURCE OF FUNDS (See Instructions)

WC

5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)

 

¨

6

CITIZENSHIP OR PLACE OF ORGANIZATION

Delaware

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
7

SOLE VOTING POWER

0

8

SHARED VOTING POWER

3,911,239

9

SOLE DISPOSITIVE POWER

0

10

SHARED DISPOSITIVE POWER

3,911,239

11

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

3,911,239

12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

 

¨

13

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

5.6%

14

TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

OO

 

 
 

 

CUSIP No. 020520102    

1

NAME OF REPORTING PERSON

I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

D. E. Shaw Heliant Manager, L.L.C.

FEIN 27-1289787

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

 

(a) ¨

(b) ¨

3 SEC USE ONLY
4

SOURCE OF FUNDS (See Instructions)

AF

5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)

 

¨

6

CITIZENSHIP OR PLACE OF ORGANIZATION

Delaware

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
7

SOLE VOTING POWER

0

8

SHARED VOTING POWER

3,911,239

9

SOLE DISPOSITIVE POWER

0

10

SHARED DISPOSITIVE POWER

3,911,239

11

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

3,911,239

12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

 

¨

13

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

5.6%

14

TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

OO

 

 
 

 

CUSIP No. 020520102    
1

NAME OF REPORTING PERSON

I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

D. E. Shaw Heliant Adviser, L.L.C.

FEIN 27-1289715

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

 

(a) ¨

(b) ¨

3 SEC USE ONLY
4

SOURCE OF FUNDS (See Instructions)

AF

5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)

 

¨

6

CITIZENSHIP OR PLACE OF ORGANIZATION

Delaware

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
7

SOLE VOTING POWER

0

8

SHARED VOTING POWER

3,911,239

9

SOLE DISPOSITIVE POWER

0

10

SHARED DISPOSITIVE POWER

3,911,239

11

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

3,911,239

12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

 

¨

13

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

5.6%

14

TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

IA

 

 
 

 

CUSIP No. 020520102    

1

NAME OF REPORTING PERSON

I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

D. E. Shaw & Co., L.L.C.

FEIN 13-3799946

2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a) ¨

(b) ¨

3 SEC USE ONLY
4

SOURCE OF FUNDS (See Instructions)

AF

5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)

 

¨

6

CITIZENSHIP OR PLACE OF ORGANIZATION

Delaware

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
7

SOLE VOTING POWER

0

8

SHARED VOTING POWER

3,911,459

9

SOLE DISPOSITIVE POWER

0

10

SHARED DISPOSITIVE POWER

3,911,459

11

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

3,911,459

12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

 

¨

13

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

5.6%

14

TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

OO

 

 
 

 

CUSIP No. 020520102    

1

NAME OF REPORTING PERSON

I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

D. E. Shaw & Co., L.P.

FEIN 13-3695715

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

 

(a) ¨

(b) ¨

3 SEC USE ONLY
4

SOURCE OF FUNDS (See Instructions)

AF

5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)

 

¨ 

6

CITIZENSHIP OR PLACE OF ORGANIZATION

Delaware

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
7

SOLE VOTING POWER

0

8

SHARED VOTING POWER

3,911,459

9

SOLE DISPOSITIVE POWER

0

10

SHARED DISPOSITIVE POWER

3,911,459

11

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

3,911,459

12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

 

¨

13

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

5.6%

14

TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

IA, PN

 

 
 

 

CUSIP No. 020520102    

1

NAME OF REPORTING PERSON

I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

David E. Shaw

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

 

(a) ¨

(b) ¨

3 SEC USE ONLY
4

SOURCE OF FUNDS (See Instructions)

AF

5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)

 

¨

6

CITIZENSHIP OR PLACE OF ORGANIZATION

United States

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
7

SOLE VOTING POWER

0

8

SHARED VOTING POWER

3,911,459

9

SOLE DISPOSITIVE POWER

0

10

SHARED DISPOSITIVE POWER

3,911,459

11

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

3,911,459

12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

 

¨

13

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

5.6%

14

TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

IN

 

 
 

 

Item 1.            Security and the Issuer

 

This statement on Schedule 13D relates to the Common Stock, par value $0.01 per share (the “Common Shares”) of Alon USA Energy, Inc. (the “Issuer”). The principal executive offices of the Issuer are located at 12700 Park Central Dr., Suite 1600, Dallas, Texas 75251.

 

Item 2.           Identity and Background

 

(a), (f) This statement is filed on behalf of D. E. Shaw Kalon Portfolios, L.L.C., a Delaware limited liability company (“Kalon Portfolios”), D. E. Shaw Heliant Manager, L.L.C., a Delaware limited liability company (“Heliant Manager”), D. E. Shaw Heliant Adviser, L.L.C., a Delaware limited liability company (“Heliant Adviser”), D. E. Shaw & Co., L.L.C., a Delaware limited liability company (“DESCO LLC”), D. E. Shaw & Co., L.P., a Delaware limited partnership (“DESCO LP”), and David E. Shaw, a citizen of the United States of America (“David E. Shaw,” and together with Kalon Portfolios, Heliant Manager, Heliant Adviser, DESCO LLC, and DESCO LP, collectively, the “Reporting Persons”). The Reporting Persons are filing jointly, and the agreement among the Reporting Persons to file jointly is attached hereto as Exhibit 3 and incorporated herein by reference.

 

(b) The business address and principal office, as applicable, of all Reporting Persons is 1166 Avenue of the Americas, 9th Floor, New York, NY 10036.

 

(c) The principal business of Kalon Portfolios is that of a limited liability company focusing primarily on macro-oriented investment strategies. Kalon Portfolios does not have any executive officers or directors. The principal business of Heliant Manager is to act as a manager to certain funds, including, without limitation, Kalon Portfolios. The principal business of Heliant Adviser is to act as an adviser to certain funds, including, without limitation, Kalon Portfolios. The principal business of DESCO LLC is to act as a manager to certain entities, including, without limitation, Heliant Manager. The principal business of DESCO LP is to act as an investment adviser to certain funds. DESCO LP is also the managing member of certain entities including, without limitation, Heliant Adviser. D. E. Shaw & Co. II, Inc., a Delaware corporation (“DESCO II Inc.”), is the managing member of DESCO LLC. D. E. Shaw & Co., Inc., a Delaware corporation (“DESCO Inc.”), is the general partner of DESCO LP. David E. Shaw is the President and sole shareholder of each of DESCO II Inc. and DESCO Inc.

 

(d) During the last five years, neither any Reporting Person nor, to the best knowledge of any Reporting Person, any person named in this Item 2, has been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).

 

(e) On September 16, 2013, DESCO LP entered into a settled administrative proceeding (the “Settlement”) with the U.S. Securities and Exchange Commission (the “SEC”) relating to inadvertent violations of Rule 105 (“Rule 105”) of Regulation M under the Securities Exchange Act of 1934. Rule 105 prohibits buying an equity security made available through a public offering, conducted on a firm basis, from an underwriter or broker or dealer participating in the offering after having sold short the same security during the restricted period as defined in the rule. Rule 105 applies irrespective of the short seller’s intent in effecting the short sale. Pursuant to the Settlement, DESCO LP paid $447,794 in disgorgement, $18,192.37 in pre-judgment interest, and a civil penalty of $201,506. The Settlement also requires that DESCO LP “cease and desist from committing or causing any violations and any future violations of Rule 105.” The SEC order implementing the Settlement notes that in determining to accept DESCO LP’s offer to enter into the Settlement, the SEC considered “remedial acts promptly undertaken” by DESCO LP and “cooperation afforded to [SEC] staff” by DESCO LP. Except with respect to the matter described above, no Reporting Person has, during the last five years, been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding has been or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

 

 
 

 

Item 3.           Source and Amount of Funds or Other Consideration

 

In acquiring 3,911,239 Common Shares, Kalon Portfolios expended approximately $55,541,309 (excluding commissions) of its working capital.

 

Item 4.           Purpose of Transaction

 

Kalon Portfolios will review its investment in the Common Shares from time to time and subject to applicable law and regulation and depending upon certain factors, including, without limitation, the financial performance of the Issuer, the availability and price of the Common Shares or other securities related to the Issuer, and other general market and investment conditions, Kalon Portfolios may determine to:

 

acquire additional Common Shares through open market purchases or otherwise; or

 

sell, trade, engage in short selling of, hedge, or enter into any similar transactions with respect to the Common Shares through the open market or otherwise.

 

Such transactions may take place at any time and without prior notice. There can be no assurance, however, that any Reporting Person will take any such actions.

 

As part of Kalon Portfolios’ ongoing review of its investments in the Common Shares, Kalon Portfolios may from time to time hold talks or discussions with, write letters to and respond to inquiries from various parties, including, without limitation, the Issuer’s Board of Directors, management or representatives, other shareholders and other persons or entities, regarding the Issuer’s affairs and strategic alternatives.

 

Kalon Portfolios may undertake from time to time, and subject to applicable law and regulation and depending upon certain factors, including, without limitation, the financial performance of the Issuer, the availability and price of the Common Shares or other securities related to the Issuer, and other general market investment conditions, Kalon Portfolios may determine to pursue various alternatives in respect of its investments in the Issuer. Such actions may include, without limitation, direct or indirect participation in the following:

 

 
 

 

forming and pursuing potential strategic developments and plans related to the Issuer;

 

seeking representation on the Board of Directors of the Issuer;

 

making recommendations to the Issuer’s Board of Directors and management of the Issuer concerning various business strategies, mergers, acquisitions, dispositions, dividend policy, capital structure, the provisions of the Issuer’s Articles of Incorporation or Bylaws or other matters;

 

seeking to acquire control of the Issuer through a merger, proxy solicitation, tender offer, exchange offer or otherwise;

 

restructuring and effecting other significant transactions with respect to the Issuer;

 

participating in a “going-private” transaction;

 

taking any other actions that could have the purpose or effect of directly or indirectly changing or influencing control of the Issuer; or

 

providing financing for any of the foregoing.

 

Such transactions may take place at any time and without prior notice. There can be no assurance, however, that the possible courses of action expressed in the immediately preceding sentence will be pursued or, if pursued, will be consummated by Kalon Portfolios or any other Reporting Person.

 

Item 5.           Interest in Securities of the Issuer

 

(a), (b) Based upon the Issuer’s Form 10-Q, filed with the SEC on May 8, 2015, there were 70,334,361 Common Shares issued and outstanding as of May 1, 2015. The 3,911,239 Common Shares beneficially owned by Kalon Portfolios (the “Kalon Shares”) represent approximately 5.6% of the Common Shares issued and outstanding. Common Shares are also beneficially owned by D. E. Shaw Oculus Portfolios, L.L.C. (“Oculus Portfolios”) and D. E. Shaw Asymptote Portfolios, L.L.C. (“Asymptote Portfolios”). The 157 Common Shares beneficially owned by Oculus Portfolios (the “Oculus Shares”) represent approximately 0.0% of the Common Shares issued and outstanding. The 63 Common Shares beneficially owned by Asymptote Portfolios (the “Asymptote Shares”) represent approximately 0.0% of the Common Shares issued and outstanding.

 

Heliant Manager, as the manager of Kalon Portfolios, and Heliant Adviser, as the investment adviser of Kalon Portfolios, may be deemed to have the shared power to vote or direct the vote of (and the shared power to dispose or direct the disposition of) the Kalon Shares.

 

DESCO LLC, as the manager of Oculus Portfolios, and the managing member of (i) Heliant Manager and (ii) D. E. Shaw Manager, L.L.C., which in turn is the manager of D. E. Shaw Asymptote Portfolios, L.L.C., may be deemed to have the shared power to vote or direct the vote of (and the shared power to dispose or direct the disposition of) the Kalon Shares, the Oculus Shares, and the Asymptote Shares (collectively the “Subject Shares”).

 

 
 

 

DESCO LP, as the investment adviser of Oculus Portfolios, and the managing member of (i) Heliant Adviser and (ii) D. E. Shaw Adviser, L.L.C., which in turn is the investment adviser of D. E. Shaw Asymptote Portfolios, L.L.C., may be deemed to have the shared power to vote or direct the vote of (and the shared power to dispose or direct the disposition of) the Subject Shares. On July 22, 2015, the Reporting Persons beneficially owned 5.6% of the outstanding shares. None of DESCO LP, DESCO LLC, Heliant Adviser, or Heliant Manager owns any of the Common Shares directly, and each of DESCO LP, DESCO LLC, Heliant Adviser, and Heliant Manager disclaims beneficial ownership of the Subject Shares.

 

David E. Shaw does not own any shares directly. By virtue of David E. Shaw’s position as President and sole shareholder of DESCO Inc., which is the general partner of DESCO LP, which in turn is the investment adviser of Oculus Portfolios, and the managing member of (i) Heliant Adviser and (ii) D. E. Shaw Adviser, L.L.C., and by virtue of David E. Shaw’s position as President and sole shareholder of DESCO II Inc., which is the managing member of DESCO LLC, which in turn is the manager of Oculus Portfolios and the managing member of (i) Heliant Manager and (ii) D. E. Shaw Manager, L.L.C., David E. Shaw may be deemed to have the shared power to vote or direct the vote of, and the shared power to dispose or direct the disposition of, the Subject Shares as described above. Therefore, David E. Shaw may be deemed to be the beneficial owner of the Subject Shares. David E. Shaw disclaims beneficial ownership of the Subject Shares.

 

As of July 22, 2015, neither any Reporting Person nor, to the best knowledge of any Reporting Person, any of the persons set forth in Item 2, owned any Common Shares other than those set forth in Item 5.

 

(c) The trading dates, number of Common Shares purchased or sold, and the price per share for all transactions by the Reporting Persons in the Common Shares from May 23, 2015 through July 22, 2015, which were all brokered transactions, are set forth below:

 

 
 

 

Name  Date  Price per Share1   Number of Shares
Purchased/(Sold)
 
Asymptote Portfolios  20150526  $16.472   (200)
DESIM  20150526  $16.353   (2,000)
D. E. Shaw Valence Portfolios, L.L.C. (“Valence Portfolios”)4  20150526  $16.415   (5,269)
Asymptote Portfolios  20150526  $16.306   200 
DESIM  20150526  $16.35    100 
Kalon Portfolios  20150526  $16.357   93,440 
Asymptote Portfolios  20150527  $16.428   (1,800)
DESIM  20150527  $16.329   (600)
Valence Portfolios  20150527  $16.4910   (12,297)
Asymptote Portfolios  20150527  $16.4711   1,800 
Valence Portfolios  20150527  $16.18    100 
Asymptote Portfolios  20150528  $16.79    (300)
DESIM  20150528  $16.6412   (800)
Valence Portfolios  20150528  $16.7113   (18,902)
Asymptote Portfolios  20150528  $16.6314   300 
Kalon Portfolios  20150528  $16.7115   15,400 
Asymptote Portfolios  20150529  $17.3516   (1,000)
DESIM  20150529  $17.5417   (400)
Oculus Portfolios  20150529  $17.46    (100)
Valence Portfolios  20150529  $17.4918   (11,988)
Asymptote Portfolios  20150529  $17.3819   1,000 
Kalon Portfolios  20150529  $17.4520   14,800 

 

 

 

1 Where weighted average price is used for the reported transactions, the Reporting Person undertakes to provide upon request by the SEC, full information regarding the number of shares purchased or sold at each separate price.

2 A weighted average price based on prices ranging from $16.34 to $16.60.

3 A weighted average price based on prices ranging from $16.25 to $16.65.

4 By virtue of David E. Shaw’s position as President and sole shareholder of D. E. Shaw & Co., Inc., which is the general partner of D. E. Shaw & Co., L.P., which in turn is the manager and investment adviser of D. E. Shaw Valence Portfolios, L.L.C., David E. Shaw may be deemed to have the shared power to vote or direct the vote of, and the shared power to dispose or direct the disposition of, shares in which Valence Portfolios transacts and, therefore, David E. Shaw may be deemed to be the beneficial owner of such shares.  David E. Shaw disclaims such beneficial ownership.

5 A weighted average price based on prices ranging from $16.24 to $16.67.

6 A weighted average price based on prices ranging from $16.28 to $16.31.

7 A weighted average price based on prices ranging from $16.24 to $16.65.

8 A weighted average price based on prices ranging from $16.31 to $16.52.

9 A weighted average price based on prices ranging from $16.22 to $16.53.

10 A weighted average price based on prices ranging from $16.20 to $16.56.

11 A weighted average price based on prices ranging from $16.35 to $16.56.

12 A weighted average price based on prices ranging from $16.44 to $16.78.

13 A weighted average price based on prices ranging from $16.49 to $16.89.

14 A weighted average price based on prices ranging from $16.62 to $16.65.

15 A weighted average price based on prices ranging from $16.44 to $16.89.

16 A weighted average price based on prices ranging from $17.01 to $17.59.

17 A weighted average price based on prices ranging from $17.48 to $17.60.

18 A weighted average price based on prices ranging from $17.06 to $17.71.

19 A weighted average price based on prices ranging from $17.23 to $17.51.

20 A weighted average price based on prices ranging from $17.07 to $17.72.

 

 
 

Name  Date  Price per Share   Number of Shares
Purchased/(Sold)
 
Asymptote Portfolios  20150601  $17.4721   (2,400)
DESIM  20150601  $17.4022   (4,600)
Valence Portfolios  20150601  $17.3023   (22,099)
Asymptote Portfolios  20150601  $17.3724   2,400 
Kalon Portfolios  20150601  $17.3125   15,000 
Asymptote Portfolios  20150602  $17.26    (100)
Oculus Portfolios  20150602  $17.41    (100)
Valence Portfolios  20150602  $17.4326   (5,771)
Asymptote Portfolios  20150602  $17.59    87 
Asymptote Portfolios  20150603  $17.3427   (500)
Valence Portfolios  20150603  $17.6028   (4,180)
Asymptote Portfolios  20150603  $17.4429   400 
Valence Portfolios  20150603  $17.2730   17,138 
Asymptote Portfolios  20150604  $17.4531   (900)
Valence Portfolios  20150604  $17.3532   (1,362)
Asymptote Portfolios  20150604  $17.3233   1,000 
DESIM  20150604  $17.3734   1,200 
Valence Portfolios  20150604  $17.3735   11,454 
Asymptote Portfolios  20150605  $17.7136   (1,600)
Oculus Portfolios  20150605  $17.6237   (7,429)
Valence Portfolios  20150605  $17.9138   (13,800)
Asymptote Portfolios  20150605  $17.8139   500 
Valence Portfolios  20150605  $17.5740   1,728 

 

 

 

21 A weighted average price based on prices ranging from $17.37 to $17.65.

22 A weighted average price based on prices ranging from $17.22 to $17.57.

23 A weighted average price based on prices ranging from $17.20 to $17.58.

24 A weighted average price based on prices ranging from $17.23 to $17.52.

25 A weighted average price based on prices ranging from $17.20 to $17.41.

26 A weighted average price based on prices ranging from $17.03 to $17.59.

27 A weighted average price based on prices ranging from $17.31 to $17.38.

28 A weighted average price based on prices ranging from $17.52 to $17.66.

29 A weighted average price based on prices ranging from $17.14 to $17.64.

30 A weighted average price based on prices ranging from $17.13 to $17.44.

31 A weighted average price based on prices ranging from $17.38 to $17.50.

32 A weighted average price based on prices ranging from $17.32 to $17.38.

33 A weighted average price based on prices ranging from $17.25 to $17.34.

34 A weighted average price based on prices ranging from $17.29 to $17.52.

35 A weighted average price based on prices ranging from $17.13 to $17.50.

36 A weighted average price based on prices ranging from $17.56 to $17.73.

37 A weighted average price based on prices ranging from $17.57 to $17.65.

38 A weighted average price based on prices ranging from $17.58 to $17.97.

39 A weighted average price based on prices ranging from $17.60 to $17.94.

40 A weighted average price based on prices ranging from $17.40 to $17.67.

 

 
 

 

Name  Date  Price per Share   Number of Shares
Purchased/(Sold)
 
Asymptote Portfolios  20150608  $17.9141   (1,650)
Valence Portfolios  20150608  $17.9342   (10,833)
Asymptote Portfolios  20150608  $17.8543   2,600 
Kalon Portfolios  20150608  $17.8844   12,700 
Valence Portfolios  20150608  $17.8545   1,400 
Asymptote Portfolios  20150609  $17.6546   (1,730)
Valence Portfolios  20150609  $17.5447   (5,344)
Asymptote Portfolios  20150609  $17.7248   1,972 
DESIM  20150609  $17.7649   200 
Kalon Portfolios  20150609  $17.5850   21,940 
Valence Portfolios  20150609  $17.8051   2,286 
Asymptote Portfolios  20150610  $18.0352   (4,400)
Valence Portfolios  20150610  $18.0253   (9,381)
Asymptote Portfolios  20150610  $18.0254   4,400 
DESIM  20150610  $18.1255   900 
Valence Portfolios  20150610  $17.8356   500 
Asymptote Portfolios  20150611  $18.0857   (1,300)
Valence Portfolios  20150611  $18.20    (71)
Asymptote Portfolios  20150611  $18.1158   1,200 
DESIM  20150611  $18.0759   1,100 
Valence Portfolios  20150611  $18.0460   3,749 
Asymptote Portfolios  20150612  $17.7861   (600)

 

 

 

41 A weighted average price based on prices ranging from $17.72 to $17.99.

42 A weighted average price based on prices ranging from $17.72 to $17.99.

43 A weighted average price based on prices ranging from $17.57 to $17.98.

44 A weighted average price based on prices ranging from $17.59 to $18.00.

45 A weighted average price based on prices ranging from $17.74 to $17.94.

46 A weighted average price based on prices ranging from $17.54 to $18.02.

47 A weighted average price based on prices ranging from $17.52 to $17.59.

48 A weighted average price based on prices ranging from $17.51 to $17.91.

49 A weighted average price based on prices ranging from $17.65 to $17.86.

50 A weighted average price based on prices ranging from $17.51 to $17.76.

51 A weighted average price based on prices ranging from $17.51 to $17.94.

52 A weighted average price based on prices ranging from $17.75 to $18.30.

53 A weighted average price based on prices ranging from $17.78 to $18.23.

54 A weighted average price based on prices ranging from $17.76 to $18.18.

55 A weighted average price based on prices ranging from $18.04 to $18.24.

56 A weighted average price based on prices ranging from $17.77 to $17.86.

57 A weighted average price based on prices ranging from $17.92 to $18.16.

58 A weighted average price based on prices ranging from $18.03 to $18.15.

59 A weighted average price based on prices ranging from $17.96 to $18.18.

60 A weighted average price based on prices ranging from $17.81 to $18.15.

61 A weighted average price based on prices ranging from $17.68 to $17.86.

 

 
 

 

Name  Date  Price per Share   Number of Shares
Purchased/(Sold)
 
DESIM  20150612  $17.7562   (300)
Asymptote Portfolios  20150612  $17.7963   700 
Valence Portfolios  20150612  $17.7864   14,500 
Asymptote Portfolios  20150615  $17.6265   (2,600)
Asymptote Portfolios  20150615  $17.5566   2,638 
Valence Portfolios  20150615  $17.5567   7,746 
Asymptote Portfolios  20150616  $17.7568   (538)
Asymptote Portfolios  20150616  $17.8969   500 
DESIM  20150616  $17.9170   800 
Valence Portfolios  20150616  $17.7571   11,722 
Asymptote Portfolios  20150617  $18.2072   (300)
Oculus Portfolios  20150617  $18.25    (200)
Asymptote Portfolios  20150617  $18.17    100 
DESIM  20150617  $18.4973   400 
Oculus Portfolios  20150617  $18.25    200 
Valence Portfolios  20150617  $18.1574   9,213 
Asymptote Portfolios  20150618  $18.7475   (900)
Kalon Portfolios  20150618  $18.7176   (7,466)
Valence Portfolios  20150618  $18.7177   (1,799)
Asymptote Portfolios  20150618  $18.6478   797 
Valence Portfolios  20150618  $18.6379   6,199 
Kalon Portfolios  20150619  $18.6080   (16,500)
Valence Portfolios  20150619  $18.7081   (725)

 

 

 

62 A weighted average price based on prices ranging from $17.72 to $17.77.

63 A weighted average price based on prices ranging from $17.67 to $17.86.

64 A weighted average price based on prices ranging from $17.60 to $18.01.

65 A weighted average price based on prices ranging from $17.53 to $17.70.

66 A weighted average price based on prices ranging from $17.48 to $17.58.

67 A weighted average price based on prices ranging from $17.49 to $17.65.

68 A weighted average price based on prices ranging from $17.63 to $18.13.

69 A weighted average price based on prices ranging from $17.61 to $18.12.

70 A weighted average price based on prices ranging from $17.65 to $18.13.

71 A weighted average price based on prices ranging from $17.50 to $18.15.

72 A weighted average price based on prices ranging from $18.03 to $18.48.

73 A weighted average price based on prices ranging from $18.29 to $18.62.

74 A weighted average price based on prices ranging from $18.00 to $18.63.

75 A weighted average price based on prices ranging from $18.69 to $18.79.

76 A weighted average price based on prices ranging from $18.59 to $18.80.

77 A weighted average price based on prices ranging from $18.66 to $18.78.

78 A weighted average price based on prices ranging from $18.37 to $18.74.

79 A weighted average price based on prices ranging from $18.52 to $18.74.

80 A weighted average price based on prices ranging from $18.45 to $18.86.

81 A weighted average price based on prices ranging from $18.65 to $18.74.

 

 
 

 

Name  Date  Price per Share   Number of Shares
Purchased/(Sold)
 
Asymptote Portfolios  20150619  $18.5682   200 
DESIM  20150619  $18.6883   500 
Valence Portfolios  20150619  $18.7984   3,044 
Asymptote Portfolios  20150622  $18.5885   (600)
DESIM  20150622  $18.58    (100)
Kalon Portfolios  20150622  $18.6186   (5,322)
Asymptote Portfolios  20150622  $18.5587   700 
DESIM  20150622  $18.6388   3,400 
Valence Portfolios  20150622  $18.5889   13,738 
DESIM  20150623  $18.7890   1,700 
Valence Portfolios  20150623  $18.7691   3,320 
Kalon Portfolios  20150624  $18.7092   (5,378)
Valence Portfolios  20150624  $18.8793   (1,300)
DESIM  20150624  $18.7694   900 
Valence Portfolios  20150624  $18.6595   1,588 
Asymptote Portfolios  20150625  $18.70    (100)
Valence Portfolios  20150625  $18.7696   (2,300)
Asymptote Portfolios  20150625  $18.75    100 
DESIM  20150625  $18.7697   1,493 
Asymptote Portfolios  20150626  $18.7198   (200)
Valence Portfolios  20150626  $18.7299   (1,590)
Asymptote Portfolios  20150626  $18.72    100 
DESIM  20150626  $18.75100   3,000 

 

 

 

82 A weighted average price based on prices ranging from $18.50 to $18.61.

83 A weighted average price based on prices ranging from $18.57 to $18.89.

84 A weighted average price based on prices ranging from $18.48 to $18.90.

85 A weighted average price based on prices ranging from $18.47 to $18.68.

86 A weighted average price based on prices ranging from $18.50 to $18.80.

87 A weighted average price based on prices ranging from $18.50 to $18.64.

88 A weighted average price based on prices ranging from $18.47 to $18.83.

89 A weighted average price based on prices ranging from $18.45 to $18.79.

90 A weighted average price based on prices ranging from $18.60 to $18.90.

91 A weighted average price based on prices ranging from $18.61 to $18.87.

92 A weighted average price based on prices ranging from $18.59 to $18.81.

93 A weighted average price based on prices ranging from $18.74 to $19.05.

94 A weighted average price based on prices ranging from $18.63 to $18.96.

95 A weighted average price based on prices ranging from $18.62 to $18.75.

96 A weighted average price based on prices ranging from $18.58 to $18.85.

97 A weighted average price based on prices ranging from $18.60 to $18.88.

98 A weighted average price based on prices ranging from $18.70 to $18.72.

99 A weighted average price based on prices ranging from $18.68 to $18.75.

100 A weighted average price based on prices ranging from $18.61 to $18.82.

 

 
 

 

Name  Date  Price per Share   Number of Shares
Purchased/(Sold)
 
Valence Portfolios  20150626  $18.73101   900 
Asymptote Portfolios  20150629  $18.64102   (600)
Kalon Portfolios  20150629  $18.55103   (6,100)
Valence Portfolios  20150629  $18.60104   (1,923)
Asymptote Portfolios  20150629  $18.53105   700 
DESIM  20150629  $18.61106   1,215 
Valence Portfolios  20150629  $18.58    200 
Asymptote Portfolios  20150630  $18.70107   (400)
Valence Portfolios  20150630  $18.91108   (8,970)
Asymptote Portfolios  20150630  $18.94109   400 
DESIM  20150630  $18.89110   1,200 
Asymptote Portfolios  20150701  $18.80111   (1,400)
Oculus Portfolios  20150701  $18.83    (100)
Valence Portfolios  20150701  $18.90112   (838)
Asymptote Portfolios  20150701  $18.76113   1,300 
DESIM  20150701  $18.89114   3,700 
Kalon Portfolios  20150701  $18.82115   11,700 
Valence Portfolios  20150701  $18.72116   806 
Asymptote Portfolios  20150702  $19.00117   (700)
Valence Portfolios  20150702  $19.00    (300)
Asymptote Portfolios  20150702  $18.86118   900 
DESIM  20150702  $18.98119   2,000 
Kalon Portfolios  20150702  $18.97120   54,100 

 

 

 

101 A weighted average price based on prices ranging from $18.60 to $18.80.

102 A weighted average price based on prices ranging from $18.58 to $18.65.

103 A weighted average price based on prices ranging from $18.44 to $18.83.

104 A weighted average price based on prices ranging from $18.51 to $18.87.

105 A weighted average price based on prices ranging from $18.45 to $18.58.

106 A weighted average price based on prices ranging from $18.49 to $18.69.

107 A weighted average price based on prices ranging from $18.68 to $18.75.

108 A weighted average price based on prices ranging from $18.69 to $18.98.

109 A weighted average price based on prices ranging from $18.92 to $18.97.

110 A weighted average price based on prices ranging from $18.82 to $18.95.

111 A weighted average price based on prices ranging from $18.73 to $18.85.

112 A weighted average price based on prices ranging from $18.76 to $19.10.

113 A weighted average price based on prices ranging from $18.65 to $18.92.

114 A weighted average price based on prices ranging from $18.73 to $19.06.

115 A weighted average price based on prices ranging from $18.70 to $18.90.

116 A weighted average price based on prices ranging from $18.66 to $18.83.

117 A weighted average price based on prices ranging from $18.94 to $19.13.

118 A weighted average price based on prices ranging from $18.80 to $19.01.

119 A weighted average price based on prices ranging from $18.82 to $19.13.

120 A weighted average price based on prices ranging from $18.87 to $19.14.

 

 
 

 

Name  Date  Price per Share   Number of Shares
Purchased/(Sold)
 
Valence Portfolios  20150702  $18.97121   2,216 
Asymptote Portfolios  20150706  $18.90122   (200)
Asymptote Portfolios  20150706  $19.03    100 
DESIM  20150706  $19.07123   2,000 
Kalon Portfolios  20150706  $19.06124   7,600 
Valence Portfolios  20150706  $19.05125   12,077 
Asymptote Portfolios  20150707  $18.67126   (1,400)
Valence Portfolios  20150707  $18.58127   (2,496)
Asymptote Portfolios  20150707  $18.47128   1,400 
DESIM  20150707  $18.72129   3,686 
Kalon Portfolios  20150707  $18.66130   71,100 
Valence Portfolios  20150707  $18.52131   11,946 
Asymptote Portfolios  20150708  $18.75132   (601)
Valence Portfolios  20150708  $17.85133   (1,238)
Valence Portfolios  20150708  $18.87    (100)
Asymptote Portfolios  20150708  $18.11134   700 
DESIM  20150708  $18.09135   2,600 
DESIM  20150708  $18.75    100 
Kalon Portfolios  20150708  $18.10136   146,910 
Kalon Portfolios  20150708  $18.77137   1,300 
Valence Portfolios  20150708  $18.15138   6,150 
Asymptote Portfolios  20150709  $18.02139   (2,400)
Valence Portfolios  20150709  $18.14140   (4,500)

 

 

 

121 A weighted average price based on prices ranging from $18.94 to $19.00.

122 A weighted average price based on prices ranging from $18.74 to $19.05.

123 A weighted average price based on prices ranging from $19.01 to $19.19.

124 A weighted average price based on prices ranging from $18.97 to $19.19.

125 A weighted average price based on prices ranging from $18.98 to $19.15.

126 A weighted average price based on prices ranging from $18.48 to $18.93.

127 A weighted average price based on prices ranging from $18.36 to $18.99.

128 A weighted average price based on prices ranging from $18.36 to $18.78.

129 A weighted average price based on prices ranging from $18.43 to $19.01.

130 A weighted average price based on prices ranging from $18.36 to $19.00.

131 A weighted average price based on prices ranging from $18.35 to $18.89.

132 A weighted average price based on prices ranging from $18.41 to $18.90.

133 A weighted average price based on prices ranging from $17.71 to $17.93.

134 A weighted average price based on prices ranging from $17.90 to $18.62.

135 A weighted average price based on prices ranging from $17.73 to $18.63.

136 A weighted average price based on prices ranging from $17.70 to $18.68.

137 A weighted average price based on prices ranging from $18.70 to $18.97.

138 A weighted average price based on prices ranging from $17.89 to $18.70.

139 A weighted average price based on prices ranging from $17.82 to $18.17.

140 A weighted average price based on prices ranging from $18.06 to $18.54.

 

 
 

 

Name  Date  Price per Share   Number of Shares
Purchased/(Sold)
 
Asymptote Portfolios  20150709  $18.15141   2,284 
DESIM  20150709  $18.04142   1,500 
Kalon Portfolios  20150709  $17.98143   30,929 
Valence Portfolios  20150709  $17.93144   5,068 
Asymptote Portfolios  20150710  $18.63145   (200)
Oculus Portfolios  20150710  $18.79146   (2,600)
Valence Portfolios  20150710  $18.42147   (800)
Asymptote Portfolios  20150710  $18.83148   300 
DESIM  20150710  $18.68149   500 
Valence Portfolios  20150710  $18.82150   27,000 
DESIM  20150713  $19.05151   2,298 
Valence Portfolios  20150713  $19.03152   13,100 
DESIM  20150714  $19.81153   2,800 
Valence Portfolios  20150714  $19.83154   30,000 
DESIM  20150715  $19.47155   1,800 
DESIM  20150716  $19.70156   1,800 
Valence Portfolios  20150716  $19.63157   2,092 
DESIM  20150717  $19.58158   1,726 
Valence Portfolios  20150717  $19.46    100 

 

(d) No person other than the Reporting Persons or any of the persons set forth in Item 2 has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Subject Shares.

 

 

 

141 A weighted average price based on prices ranging from $17.93 to $18.23.

142 A weighted average price based on prices ranging from $17.75 to $18.27.

143 A weighted average price based on prices ranging from $17.81 to $18.00.

144 A weighted average price based on prices ranging from $17.75 to $18.07.

145 A weighted average price based on prices ranging from $18.46 to $18.79.

146 A weighted average price based on prices ranging from $18.70 to $18.92.

147 A weighted average price based on prices ranging from $18.36 to $18.45.

148 A weighted average price based on prices ranging from $18.74 to $18.88.

149 A weighted average price based on prices ranging from $18.46 to $18.83.

150 A weighted average price based on prices ranging from $18.70 to $18.91.

151 A weighted average price based on prices ranging from $18.91 to $19.13.

152 A weighted average price based on prices ranging from $18.87 to $19.06.

153 A weighted average price based on prices ranging from $19.63 to $19.91.

154 A weighted average price based on prices ranging from $19.63 to $19.93.

155 A weighted average price based on prices ranging from $19.16 to $19.68.

156 A weighted average price based on prices ranging from $19.55 to $19.89.

157 A weighted average price based on prices ranging from $19.55 to $19.71.

158 A weighted average price based on prices ranging from $19.45 to $19.80.

 

 
 

 

(e) Not Applicable.

 

Item 6.           Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer

 

Valence Portfolios maintains an open short position of 151,192 Common Shares, and accounts under the management of DESIM maintain open short positions of 179,123 Common Shares.

 

Except for the matters described herein, neither the Reporting Persons nor, to the best knowledge of any Reporting Person, any of the person listed in Item 2 has any contract, arrangement, understanding or relationship with any person with respect to any securities of the Issuer.

 

Item 7.           Material to be filed as Exhibits

 

Exhibit 1Power of Attorney, granted by David E. Shaw relating to D. E. Shaw & Co., Inc., in favor of the signatories hereto, among others, dated December 16, 2014.

 

Exhibit 2Power of Attorney, granted by David E. Shaw relating to D. E. Shaw & Co. II, Inc., in favor of the signatories hereto, among others, dated December 16, 2014.

 

Exhibit 3Joint Filing Agreement, by and among the Reporting Persons, dated July 22, 2015.

 

 
 

 

SIGNATURES

 

After reasonable inquiry and to the best of each of the undersigned’s knowledge and belief, each of the undersigned, severally and not jointly, certifies that the information set forth in this statement is true, complete and correct. Powers of Attorney, dated December 16, 2014, granted by David E. Shaw in favor of Nathan Thomas, are attached hereto as Exhibits 1 and 2 and incorporated herein by reference.

 

Dated:           July 22, 2015

 

  D. E. Shaw Kalon Portfolios, L.L.C.
   
  By: /s/ Nathan Thomas
    Nathan Thomas
    Authorized Signatory
     
  D. E. Shaw Heliant Manager, L.L.C.
   
  By: /s/ Nathan Thomas
    Nathan Thomas
    Authorized Signatory
     
  D. E. Shaw Heliant Adviser, L.L.C.
   
  By: /s/ Nathan Thomas
    Nathan Thomas
    Chief Compliance Officer
   
  D. E. Shaw & Co., L.L.C.
   
  By: /s/ Nathan Thomas
    Nathan Thomas
    Authorized Signatory
   
  D. E. Shaw & Co., L.P.
   
  By: /s/ Nathan Thomas
    Nathan Thomas
    Chief Compliance Officer
   
  David E. Shaw
   
  By: /s/ Nathan Thomas
    Nathan Thomas
    Attorney-in-Fact for David E. Shaw

 

 

 



Exhibit 1

 

POWER OF ATTORNEY

FOR CERTAIN REGULATORY FILINGS

INCLUDING CERTAIN FILINGS

UNDER THE SECURITIES EXCHANGE ACT OF 1934

AND THE INVESTMENT ADVISERS ACT OF 1940

 

I, David E. Shaw, hereby make, constitute, and appoint each of:

 

Anne Dinning,

 

Julius Gaudio,

 

John Liftin,

 

Maximilian Stone,

 

Nathan Thomas, and

 

Eric Wepsic,

 

acting individually, as my agent and attorney-in-fact, with full power of substitution, for the purpose of, from time to time, (i) executing in my name and/or my capacity as President of D. E. Shaw & Co., Inc. (acting for itself or as the general partner of D. E. Shaw & Co., L.P. and general partner, managing member, or manager of other entities, any of which in turn may be acting for itself or other entities) all documents, certificates, instruments, statements, other filings, and amendments to the foregoing (collectively, “documents”) determined by such person to be necessary or appropriate to comply with any registration or regulatory disclosure requirements and/or ownership or control-person reporting requirements imposed by any United States or non-United States governmental or regulatory authority, including without limitation Form ADV, Forms 3, 4, 5, and 13F, and Schedules 13D and 13G required to be filed with the United States Securities and Exchange Commission, and (ii) delivering, furnishing, or filing any such documents to or with the appropriate governmental or regulatory authority. Any such determination shall be conclusively evidenced by such person’s execution, delivery, furnishing, and/or filing of the applicable document.

 

This power of attorney shall be valid from the date hereof and replaces the power granted on June 22, 2012, which is hereby cancelled.

 

IN WITNESS HEREOF, I have executed this instrument as of the date set forth below.

 

Date: December 16, 2014

 

DAVID E. SHAW, as President of

D. E. Shaw & Co., Inc.

/s/ David E. Shaw

New York, New York

 

 

 



Exhibit 2

 

POWER OF ATTORNEY

FOR CERTAIN REGULATORY FILINGS

INCLUDING CERTAIN FILINGS

UNDER THE SECURITIES EXCHANGE ACT OF 1934

AND THE INVESTMENT ADVISERS ACT OF 1940

 

I, David E. Shaw, hereby make, constitute, and appoint each of:

 

Anne Dinning,

 

Julius Gaudio,

 

John Liftin,

 

Maximilian Stone,

 

Nathan Thomas, and

 

Eric Wepsic,

 

acting individually, as my agent and attorney-in-fact, with full power of substitution, for the purpose of, from time to time, (i) executing in my name and/or my capacity as President of D. E. Shaw & Co. II, Inc. (acting for itself or as the managing member of D. E. Shaw & Co., L.L.C. and general partner, managing member, or manager of other entities, any of which in turn may be acting for itself or other entities) all documents, certificates, instruments, statements, other filings, and amendments to the foregoing (collectively, “documents”) determined by such person to be necessary or appropriate to comply with any registration or regulatory disclosure requirements and/or ownership or control-person reporting requirements imposed by any United States or non-United States governmental or regulatory authority, including without limitation Form ADV, Forms 3, 4, 5, and 13F, and Schedules 13D and 13G required to be filed with the United States Securities and Exchange Commission, and (ii) delivering, furnishing, or filing any such documents to or with the appropriate governmental or regulatory authority. Any such determination shall be conclusively evidenced by such person’s execution, delivery, furnishing, and/or filing of the applicable document.

 

This power of attorney shall be valid from the date hereof and replaces the power granted on June 22, 2012, which is hereby cancelled.

 

IN WITNESS HEREOF, I have executed this instrument as of the date set forth below.

 

Date: December 16, 2014

 

DAVID E. SHAW, as President of

D. E. Shaw & Co. II, Inc.

/s/ David E. Shaw

New York, New York

 

 

 



Exhibit 3

 

JOINT FILING AGREEMENT

 

In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, each of the undersigned Reporting Persons hereby agrees to the joint filing, along with all other such Reporting Persons, on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to the Common Stock, par value $0.01 per share, of Alon USA Energy, Inc., and that this agreement be included as an Exhibit to such joint filing. This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.

 

IN WITNESS WHEREOF, each of the undersigned hereby executes this Agreement as of this 22nd day of July, 2015.

 

  D. E. Shaw Kalon Portfolios, L.L.C.
   
  By: /s/ Nathan Thomas
    Nathan Thomas
    Authorized Signatory
     
  D. E. Shaw Heliant Manager, L.L.C.
   
  By: /s/ Nathan Thomas
    Nathan Thomas
    Authorized Signatory
   
  D. E. Shaw Heliant Adviser, L.L.C.
   
  By: /s/ Nathan Thomas
    Nathan Thomas
    Chief Compliance Officer
   
  D. E. Shaw & Co., L.L.C.
   
  By: /s/ Nathan Thomas
    Nathan Thomas
    Authorized Signatory
   
  D. E. Shaw & Co., L.P.
   
  By: /s/ Nathan Thomas
    Nathan Thomas
    Chief Compliance Officer
   
  David E. Shaw
   
  By: /s/ Nathan Thomas
    Nathan Thomas
    Attorney-in-Fact for David E. Shaw

 

 

 

Alon (NYSE:ALJ)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Alon Charts.
Alon (NYSE:ALJ)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Alon Charts.